文献速递小儿骨科关节外科

股骨粗隆下移术治疗Legg-Calvé-Perthes病在股骨内翻去旋转截骨术后的长期临床与影像学结局随访研究

A long-term follow-up study of the clinical and radiographic outcome of distal trochanteric transfer in Legg-Calvé-Perthes' disease following varus derotational osteotomy.
PubMed 文献 · Bone Joint J · 2017-01-01

该单中心横断面回顾性研究分析了22例(24髋)Legg-Calvé-Perthes病(LCPD)患者,这些患者在接受股骨内翻去旋转截骨术(VDRO)后出现大粗隆过度生长(GTO,关节粗隆距离ATD<5 mm)。研究比较了接受股骨粗隆下移术(DTT)的10例(10髋)与未接受DTT的12例(14髋)患者的长期影像学和临床结局。结果显示DTT组ATD和中心粗隆距离(CTD)显著优于对照组(p<0.001),但Harris髋关节评分(HHS)、SF-36评分及骨关节炎发生率两组无显著差异。

要点

  • DTT组ATD为21.7 mm(标准差9.8),对照组为-0.6 mm(标准差7.8),差异有统计学意义(p<0.001)。
  • DTT组HHS平均68.4(标准差25.0),对照组73.2(标准差24.2),差异无统计学意义(p=0.63)。
  • DTT组SF-36平均62.0(标准差27.7),对照组73.3(标准差21.5),差异无统计学意义(p=0.25)。

核心结论

  • 尽管DTT在长期随访中改善了VDRO后GTO患者的影像学结果,但在HHS、SF-36或骨关节炎发生率方面与未接受DTT的患者相比未见临床获益。

研究设计与样本

  • 单中心横断面回顾性研究,分析1959年至1983年间在本机构接受VDRO后出现GTO的22例(24髋)LCPD患者。
  • GTO定义为关节粗隆距离(ATD)<5 mm。
  • 比较接受DTT治疗GTO的10例(10髋)与未接受DTT的12例(14髋)患者的影像学和临床结局。
  • DTT组就诊年龄为6.9岁(范围4至10岁),对照组为8.0岁(范围3.2至12岁)。
  • 使用Harris髋关节评分(HHS)和SF-36问卷评估髋相关症状和一般生活质量。

主要发现

  • DTT组长期随访时ATD为21.7 mm(标准差9.8),CTD为13.8 mm(标准差8.3);对照组ATD为-0.6 mm(标准差7.8),CTD为32.5 mm(标准差10.2);差异有统计学意义(p<0.001)。
  • DTT组HHS平均68.4(标准差25.0),SF-36平均62.0(标准差27.7);对照组HHS平均73.2(标准差24.2),SF-36平均73.3(标准差21.5);HHS差异无统计学意义(p=0.63),SF-36差异无统计学意义(p=0.25)。
  • DTT组4例(40%)接受髋关节置换术,对照组1例(7.1%)(p=0.07);DTT组置换时平均年龄45.3岁(范围42.1至56.5岁),对照组为43.6岁。
  • DTT组6例(60%)患有中重度骨关节炎(Tönnis 2级或3级),对照组8例(57.1%)(p=0.61)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To assess the long-term effect of distal trochanteric transfer (DTT) on the clinical and radiographic outcomes of patients with Legg-Calvé-Perthes' disease (LCPD) following a varus derotational osteotomy (VDRO). PATIENTS AND METHODS: For this single centre cross-sectional retrospective study we analysed the data of 22 patients (24 hips) with LCPD who had greater trochanteric overgrowth (GTO), following a VDRO performed in our institution between 1959 and 1983. GTO was defined as an articular trochanteric distance (ATD) of < 5 mm. We compared the radiographic and clinical outcomes of patients who underwent DTT for GTO (ten patients, ten hips) with those who did not (12 patients, 14 hips). Age at presentation was 6.9 years (4 to 10) and 8.0 years (3.2 to 12) respectively. Symptoms associated with the hip and general quality of life were assessed using the Harris hip score (HHS) and the Short Form (SF)-36 questionnaires. RESULTS: At long-term follow-up of the DTT group, the ATD was 21.7 mm (standard deviation (sd) 9.8) and the centro-trochanteric distance (CTD) was 13.8 mm (sd 8.3). In the control group the ATD was -0.6 mm (sd 7.8) and the CTD was 32.5 mm (sd 10.2). These differences were statistically significant (p < 0.001). The mean HHS and SF-36 scores were 68.4 (sd 25.0) and 62.0 (sd 27.7) for the DTT group and 73.2 (sd 24.2) and 73.3 (sd 21.5) for the control group, respectively. There was no statistically significant difference in the HHS (p = 0.63) or SF-36 score (p = 0.25). There were four patients who had undergone hip arthroplasty in the DTT group (40%) and one patient (7.1%) in the control group (p = 0.07). The mean age at the time of arthroplasty was 45.3 years (42.1 to 56.5) and 43.6 years respectively. Six patients in the DTT group suffered from moderate to severe osteoarthritis (Tönnis grade 2 or 3) compared with eight patients in the control group (60% versus 57.1%, p = 0.61). CONCLUSION: Although DTT improved the radiographic results in the long-term follow-up of patients with GTO following VDRO, there was no clinical benefit seen in the HHS, SF-36 or incidence of osteoarthritis compared with patients who had not undergone DTT. Cite this article: Bone Joint J 2017;99-B:987-92.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Shohat N, Gilat R, Shitrit R, et al. A long-term follow-up study of the clinical and radiographic outcome of distal trochanteric transfer in Legg-Calvé-Perthes' disease following varus derotational osteotomy. Bone Joint J. 2017. PMID: 28663408. doi:10.1302/0301-620X.99B7.BJJ-2016-1346.R2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。